Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.63%
SPX
-0.33%
IXIC
-0.22%
FTSE
-0.38%
N225
-0.19%
AXJO
-0.11%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

About

What does CYCC do?
Cyclacel Pharmaceuticals, based in Berkeley Heights, New Jersey, develops cancer medicines focusing on cell cycle and transcriptional regulation. Its key programs include fadraciclib and plogosertib, targeting solid tumors and hematological malignancies.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New Jersey, USA
Website
http://www.cyclacel.com

Recently from Cashu

publisher logo
Cashu

It seems that there is no content provided for summarization. Please share the text you would like me to summarize, and I'll be happy to help!

8 days ago
publisher logo
Cashu

Cyclacel Pharmaceuticals: Key Updates and Developments in Clinical Research and Market Position

9 days ago
publisher logo
Cashu

Cyclacel Pharmaceuticals: Key Updates and Future Prospects for Investors

23 days ago

Key Stats

Market Cap
97.19K
Dividend Yield
0.00%
P/E Ratio
-0.01
EPS
-3.22
Revenue
43.00K
Avg. Volume
25.82M
Stocks
Health Care
cycc
Cyclacel Pharmaceuticals
CYCC
-0.41 (-9.76%)
3.79
USD
At close at Jul 11, 20:37 UTC
Summary
News
Signals
Benchmarks
Financials